116 related articles for article (PubMed ID: 16682282)
1. Evaluation of microsatellite amplifications at chromosomal locus 3q26 as surrogate marker for premalignant changes in mucosa surrounding head and neck squamous cell carcinoma.
Brieger J; Kastner J; Gosepath J; Mann WJ
Cancer Genet Cytogenet; 2006 May; 167(1):26-31. PubMed ID: 16682282
[TBL] [Abstract][Full Text] [Related]
2. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.
Redon R; Muller D; Caulee K; Wanherdrick K; Abecassis J; du Manoir S
Cancer Res; 2001 May; 61(10):4122-9. PubMed ID: 11358835
[TBL] [Abstract][Full Text] [Related]
3. Allelotype of head and neck squamous cell carcinoma.
Nawroz H; van der Riet P; Hruban RH; Koch W; Ruppert JM; Sidransky D
Cancer Res; 1994 Mar; 54(5):1152-5. PubMed ID: 8118797
[TBL] [Abstract][Full Text] [Related]
4. Allelic imbalance on chromosomes 3p, 9p and 17p in malignant progression of laryngeal mucosa.
Guo T; Sun JW; Lv QP; Li XG
J Laryngol Otol; 2008 Jan; 122(1):72-7. PubMed ID: 17498326
[TBL] [Abstract][Full Text] [Related]
5. Detection of head and neck squamous cell carcinoma among exfoliated oral mucosal cells by microsatellite analysis.
Spafford MF; Koch WM; Reed AL; Califano JA; Xu LH; Eisenberger CF; Yip L; Leong PL; Wu L; Liu SX; Jerónimo C; Westra WH; Sidransky D
Clin Cancer Res; 2001 Mar; 7(3):607-12. PubMed ID: 11297256
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of head and neck tumors by analysis of telomerase activity and a panel of microsatellite markers.
Fiedler W; Hoppe C; Schimmel B; Koscielny S; Dahse R; Bereczki Z; Claussen U; Ernst G; von Eggeling F
Int J Mol Med; 2002 Apr; 9(4):417-23. PubMed ID: 11891539
[TBL] [Abstract][Full Text] [Related]
7. Detection of plasma tumor DNA in head and neck squamous cell carcinoma by microsatellite typing and p53 mutation analysis.
Coulet F; Blons H; Cabelguenne A; Lecomte T; Lacourreye O; Brasnu D; Beaune P; Zucman J; Laurent-Puig P
Cancer Res; 2000 Feb; 60(3):707-11. PubMed ID: 10676657
[TBL] [Abstract][Full Text] [Related]
8. Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications.
Tabor MP; Brakenhoff RH; van Houten VM; Kummer JA; Snel MH; Snijders PJ; Snow GB; Leemans CR; Braakhuis BJ
Clin Cancer Res; 2001 Jun; 7(6):1523-32. PubMed ID: 11410486
[TBL] [Abstract][Full Text] [Related]
9. Genetic progression and clonal relationship of recurrent premalignant head and neck lesions.
Califano J; Westra WH; Meininger G; Corio R; Koch WM; Sidransky D
Clin Cancer Res; 2000 Feb; 6(2):347-52. PubMed ID: 10690509
[TBL] [Abstract][Full Text] [Related]
10. Genetic progression model for head and neck cancer: implications for field cancerization.
Califano J; van der Riet P; Westra W; Nawroz H; Clayman G; Piantadosi S; Corio R; Lee D; Greenberg B; Koch W; Sidransky D
Cancer Res; 1996 Jun; 56(11):2488-92. PubMed ID: 8653682
[TBL] [Abstract][Full Text] [Related]
11. p53-positive tumor-distant squamous epithelia of the head and neck reveal selective loss of chromosome 17.
Wolf C; Flechtenmacher C; Dietz A; Weidauer H; Abel U; Maier H; Bosch FX
Laryngoscope; 2004 Apr; 114(4):698-704. PubMed ID: 15064627
[TBL] [Abstract][Full Text] [Related]
12. Genetic discordance between primary tumours and metastases of head and neck cancer detected by microsatellite analysis.
Götte K; Riedel F; Schäfer C; Coy JF; Hörmann K
Oncol Rep; 2002; 9(4):829-34. PubMed ID: 12066217
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial C-tract alteration in premalignant lesions of the head and neck: a marker for progression and clonal proliferation.
Ha PK; Tong BC; Westra WH; Sanchez-Cespedes M; Parrella P; Zahurak M; Sidransky D; Califano JA
Clin Cancer Res; 2002 Jul; 8(7):2260-5. PubMed ID: 12114429
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of RAD17 in head and neck cancer.
Zhao M; Begum S; Ha PK; Westra W; Califano J
Head Neck; 2008 Jan; 30(1):35-42. PubMed ID: 17657792
[TBL] [Abstract][Full Text] [Related]
15. Tumor-specific methylation in saliva: a promising biomarker for early detection of head and neck cancer recurrence.
Righini CA; de Fraipont F; Timsit JF; Faure C; Brambilla E; Reyt E; Favrot MC
Clin Cancer Res; 2007 Feb; 13(4):1179-85. PubMed ID: 17317827
[TBL] [Abstract][Full Text] [Related]
16. Chromosomal alterations during metastasis formation of head and neck squamous cell carcinoma.
Bockmühl U; Schlüns K; Schmidt S; Matthias S; Petersen I
Genes Chromosomes Cancer; 2002 Jan; 33(1):29-35. PubMed ID: 11746985
[TBL] [Abstract][Full Text] [Related]
17. DNA copy number gains in head and neck squamous cell carcinoma.
Lin M; Smith LT; Smiraglia DJ; Kazhiyur-Mannar R; Lang JC; Schuller DE; Kornacker K; Wenger R; Plass C
Oncogene; 2006 Mar; 25(9):1424-33. PubMed ID: 16247453
[TBL] [Abstract][Full Text] [Related]
18. Head and neck cancer and precancer: can we use molecular genetics to make better predictions?
Partridge M
Ann R Coll Surg Engl; 1999 Jan; 81(1):1-11. PubMed ID: 10325677
[No Abstract] [Full Text] [Related]
19. Chromosomal aberrations in premalignant and malignant squamous epithelium.
Brieger J; Jacob R; Riazimand HS; Essig E; Heinrich UR; Bittinger F; Mann WJ
Cancer Genet Cytogenet; 2003 Jul; 144(2):148-55. PubMed ID: 12850378
[TBL] [Abstract][Full Text] [Related]
20. Molecular discrimination of multiple primary versus metastatic squamous cell cancers of the head/neck and lung.
Mercer RR; Lucas NC; Simmons AN; Zander DS; Tsongalis GJ; Funkhouser WK; Coleman WB
Exp Mol Pathol; 2009 Feb; 86(1):1-9. PubMed ID: 19094981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
